Immunic (IMUX) Minority Interest (2013 - 2014)

Immunic (IMUX) reported Minority Interest of $103.3 million for Q1 2014, up 7504.78% sequentially from $1.4 million in Q4 2013.

Immunic (IMUX) Minority Interest (2013 - 2014) Analysis & Trends

Immunic (IMUX) has 2 years of Minority Interest data on file, last reported at $103.3 million in Q1 2014.

For the quarter ending Q1 2014, Minority Interest changed N/A year-over-year to $103.3 million; the trailing twelve-month figure through Mar 2014 stood at $103.3 million (changed N/A YoY), and the FY2013 full-year result was $1.4 million, changed N/A from the prior year.
Minority Interest climbed to $103.3 million in Q1 2014, from $1.4 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $103.3 million in Q1 2014 to a low of $1.4 million in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Immunic	11.03 Mn	11.03 Mn	-

Download Data

Date	Value
Mar 31, 2014	103.35 Mn
Dec 31, 2013	1.36 Mn